Syndex Bio
Overview
0 The science How mcPCR works. In mcPCR the native 5mC methylation patterns in template DNA are preserved during DNA amplification.
Funding and backers
Total raised
$15.5M
1 round on record
Latest round
$15.5M
Seed · Feb 2025 · 20 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
20 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 23
Launched Syndex Bio unveils mcPCR technology at AGBT 2026 following $15.5 M seed financing · NewsMedical
Feb 27, 2025
Raised a round Seed $15.5M · SEC Form D
2022
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Feb 2025 | $15.5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Syndex Bio Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Geoff SmithExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Amped PCR delivers advanced, high-performance PCR reagents to help scientists achieve reliable, fast, and accurate DNA amplification…
Hepta is decoding tissue-level biology from blood, starting with MASH. LiquidTransformer, our liquid biopsy-native AI platform, reads…
ゲノム （ DNA ）、エピゲノム、トランスクリプトーム （ RNA ）を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス（ NGS ）／ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.
Biomodal's duet platform reads genetics, methylation and fragmentomics from the same DNA molecule — integrated multiomic insight from a…
3X4 Genetics offers DNA genetic testing that tells you everything you need to know about your body. Learn how to manage your health with…
Optimize health with advanced DNA methylation testing & personalized action plan. Biomarkers for anti-aging assessments across 21 body…
Financials
Total raised
$15.5M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2025 | $15.5M | Details |
People
Geoff Smith
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
Report
Syndex Bio unveils mcPCR technology at AGBT 2026 following $15.5 M seed financing
Syndex Bio, a biotechnology company advancing next-generation molecular diagnostics, today announced the introduction of its proprietary mcPCR (methyl-copying PCR) platform at the Advances in Genome Biology and Technology (AGBT) conference in Orlando, Flo
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Santa Monica
United States
HQ
50-200 est. staff